Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

50%

3 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4

2(50.0%)

Phase 3

1(25.0%)

N/A

1(25.0%)

4Total

Phase 4(2)

Phase 3(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT04965324Active Not Recruiting

Depth of Anaesthesia and Long-term Survival: The Balanced Anaesthesia Follow-up Study

Role: collaborator

NCT04316013Phase 3Terminated

Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial

Role: collaborator

NCT02020538Not ApplicableCompleted

Limiting IV Chloride to Reduce AKI After Cardiac Surgery

Role: collaborator

NCT00226876Completed

Dreaming During Anaesthesia and Anaesthetic Depth

Role: collaborator

NCT00226837Phase 4Completed

Quantifying Nitrous Oxide Effect on Depth of Anaesthesia Using Theoretically Based Time Series Modelling

Role: collaborator

NCT00286650Phase 4Completed

Comparison of Two Different Doses of Paracetamol for Post-Operative Pain Relief

Role: collaborator

All 6 trials loaded